Quarterly report pursuant to Section 13 or 15(d)

Fair Value of Financial Instruments (Tables)

v3.21.2
Fair Value of Financial Instruments (Tables)
9 Months Ended
Sep. 30, 2021
Investments, All Other Investments [Abstract]  
Schedule of Liabilities Measured Fair Value on Recurring Basis

Liabilities measured at fair value on a recurring basis consisted of the following at September 30, 2021 and December 31, 2020:

Schedule of Liabilities Measured Fair Value on Recurring Basis 

    September 30, 2021    

Quoted Prices in

Active Markets for Identical Assets

(Level 1)

   

Significant Other

Observable

Inputs

(Level 2)

   

Significant Unobservable Inputs

(Level 3)

 
                                 
Derivative liabilities   $ 1,567,508     $ -     $ -     $ 1,567,508  

 

 

    December 31, 2020    

Quoted Prices in Active Markets for

Identical Assets

(Level 1)

   

Significant Other Observable

Inputs

(Level 2)

   

Significant Unobservable Inputs

(Level 3)

 
Derivative liabilities   $ 1,357,528     $ -     $ -     $ 1,357,528